Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Amgen’s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss injection. That fueled investor concerns about new competition in the rapidly…